Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
批准号:
10723140
负责人:
Paula Anne Newman-Casey
金额:
$14.24万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-01 至 2025-07-31
关键词:
AddressAdherenceAdultAfrican AmericanAfrican American populationBehaviorBlindnessCaringCharacteristicsClinicClinicalClinical Practice GuidelineCommunicationCompetenceConsolidated Framework for Implementation ResearchCounselingDataDiabetes MellitusDiagnosisDiseaseDisparityDistressDoseEconomically Deprived PopulationEconomicsEducationEffectiveness of InterventionsElectronicsEnrollmentEvaluationEyedropsFocus GroupsFundingFutureGlaucomaGoalsHealth EducatorsHealth PersonnelHealth behaviorHigh PrevalenceIncomeInterventionLow incomeMediatingMediatorMethodsMinority GroupsModelingMonitorMotivationNational Eye InstituteOutcomeParticipantPatientsPersonsPharmaceutical PreparationsPhysiciansPhysiologic Intraocular PressurePilot ProjectsProviderPsychosocial InfluencesRaceReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationReminder SystemsResearchSamplingSelf DeterminationSelf ManagementShapesSurveysTechnologyTelephoneTest ResultTestingTextTimeTrainingTrustVisionVisualWorkbehavior changeblindcomparative efficacycosteHealtheffective therapyempowermentevidence baseexperienceimplementation facilitatorsimplementation interventionimplementation studyimprovedintervention participantslow socioeconomic statusmedication compliancemotivational enhancement therapynoveloutreachparticipant interviewpreferencepreservationprogramspsychologicracial disparityrandomized, clinical trialsrecruitsatisfactionskillssocial disparitiessociodemographicssocioeconomic disparitystandard caretheoriestool
中文摘要
项目摘要
尽管有有效的治疗方法,青光眼导致更多的人成为不可逆的失明,
世界范围内的任何其他疾病,特别是在社会和经济弱势群体中。80%的
患者不坚持他们的处方青光眼药物。非裔美国人和低收入人群
社会经济地位更有可能经历不良的药物依从性和不良视力相关
结果。因为改善的依从性与青光眼引起的视力丧失减少有关,
迫切需要更好地支持青光眼患者的各种自我管理需求。我们的长期
我们的目标是通过以下措施,
更有效地让他们参与青光眼自我管理行为。我们的科学前提是基于
之前严格的国家眼科研究所资助的工作表明,需要改善自我管理
青光眼的治疗方法循证交流、教育和外联战略,
作为量身定制的教育,基于动机访谈(MI)的咨询和提醒系统,可以改善
不同患者的依从性和结局。我们的中心假设是,青光眼患者,
参与支持、教育和赋权(SEE)计划的患者将改善他们的药物治疗
坚持。在SEE计划中,参与者将获得1)由电子健康生成的个性化教育
由一名受过培训的健康教育工作者亲自提供申请,并结合基于MI的咨询,
青光眼教练和2)针对参与者偏好定制的提醒,包括听觉或视觉警报和/或
短信或电话通知。我们的总体目标是测试SEE计划,
与标准治疗相比,通过在230名患者中进行的随机临床试验,
入组时药物依从性差的青光眼患者。SEE计划的重要组成部分
是它包含了非医生的健康护理提供者--健康教育者--来提供教育,
咨询和支持,青光眼患者的依从性差需要。影响:完成后,
试验,我们将严格评估一种干预措施,这种干预措施具有高度可扩展性和可持续性,因为它
电子保健技术的应用和非医生提供者的使用。这项研究的证据将
为有效改变行为战略和方法提供信息,以解决
青光眼结果。最终,我们的研究结果将通过促进和塑造临床实践指南,
改善药物依从性和视力结果的循证模型。
英文摘要
PROJECT ABSTRACT
Despite the availability of effective treatments, glaucoma causes more people to become irreversibly blind than
any other disease worldwide, especially among socially and economically disadvantaged groups. 80% of
patients do not adhere to their prescribed glaucoma medications. African Americans and people with lower
socio-economic status are more likely to experience poor medication adherence and adverse vision-related
outcomes. Because improved adherence is associated with decreased vision loss from glaucoma, there is a
critical need to better support the diverse self-management needs of people with glaucoma. Our long-term
goal is to substantially increase glaucoma medication adherence among patients from diverse backgrounds by
more effectively engaging them in glaucoma self-management behaviors. Our scientific premise is based on
prior rigorous National Eye Institute-funded work demonstrating the need for improved self-management
support for patients with glaucoma. Evidence-based communication, education, and outreach strategies, such
as tailored education, motivational-interviewing (MI) based counseling and reminder systems, can improve
adherence and outcomes for diverse patients. Our central hypothesis is that glaucoma patients with poor
adherence who participate in the Support, Educate and Empower (SEE) Program will improve their medication
adherence. In the SEE Program, participants receive 1) Personally tailored education generated by an eHealth
application delivered in-person combined with MI-based counseling from a health educator trained as a
glaucoma coach and 2) reminders tailored to participant preference including audible or visual alerts and/or
text or phone calls when a dose is missed. Our overall objective is to test whether the SEE Program,
compared to standard care, improves medication adherence through a randomized clinical trial among 230
glaucoma patients with poor medication adherence at enrollment. An essential component of the SEE Program
is its inclusion of non-physician health care providers—health educators— to provide the education,
counseling, and support that glaucoma patients with poor adherence require. Impact: Upon completion of the
trial, we will have rigorously evaluated an intervention that is highly scalable and sustainable due to its
application of eHealth technologies and use of non-physician providers. The evidence from this study will
inform effective behavior-change strategies and approaches to address racial and socioeconomic disparities in
glaucoma outcomes. Ultimately, our findings will inform and shape clinical practice guidelines by promoting
evidence-based models that improve medication adherence and visual outcomes.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1177/17407745221136571
发表时间:
2023-04
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
[]
通讯作者:
Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program.
支持、教育、授权个性化青光眼辅导计划一年后青光眼药物的依从性。
DOI:
10.1016/j.ogla.2022.08.001
发表时间:
2023
期刊:
Ophthalmology. Glaucoma
影响因子:
--
作者:
[Killeen,OliviaJ, Niziol,LeslieM, Cho,Juno, Heisler,Michele, Resnicow,Ken, Darnley-Fisch,Deborah, Musch,DavidC, Lee,PaulP, Newman-Casey,PaulaAnne]
通讯作者:
Newman-Casey,PaulaAnne
Emerging glaucoma treatments: are we seeing an improvement in adherence?
新出现的青光眼治疗:我们是否看到依从性有所改善?
DOI:
10.1080/17469899.2023.2199981
发表时间:
2023
期刊:
Expert review of ophthalmology
影响因子:
0.7
作者:
[Droste,AndrewP, Newman-Casey,PaulaAnne]
通讯作者:
Newman-Casey,PaulaAnne
DOI:
10.1097/ico.0000000000002680
发表时间:
2021-12-01
期刊:
Cornea
影响因子:
2.8
作者:
[Khan M, Michelson S, Newman-Casey PA, Woodward MA]
通讯作者:
Woodward MA
Assessing Eye Health and Eye Care Needs Among North American Native Individuals.
评估北美原住民的眼睛健康和眼睛护理需求。
DOI:
10.1001/jamaophthalmol.2021.5507
发表时间:
2022
期刊:
JAMA ophthalmology
影响因子:
8.1
作者:
[Woodward,MariaA, Hughes,Kathleen, Ballouz,Dena, Hirth,RichardA, Errickson,Josh, Newman-Casey,PaulaAnne]
通讯作者:
Newman-Casey,PaulaAnne
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
-
批准号:10460450
-
项目类别:
-
资助金额:$70.64万
-
财政年份:2020
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
-
批准号:10232076
-
项目类别:
-
资助金额:$73.14万
-
财政年份:2020
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial: Diversity Supplement
-
批准号:10577970
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2020
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Sustainable Community Clinic Telemedicine-Based Glaucoma Screening
-
批准号:10001406
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2019
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Sustainable Community Clinic Telemedicine-Based Glaucoma Screening
-
批准号:10412890
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2019
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Sustainable Community Clinic Telemedicine-Based Glaucoma Screening
-
批准号:10357550
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2019
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Sustainable Community Clinic Telemedicine-Based Glaucoma Screening
-
批准号:10726497
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2019
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Improving glaucoma self-management with technology-supported counselors
-
批准号:9264536
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2016
-
负责人:Paula Anne Newman-Casey
-
依托单位:
Improving glaucoma self-management with technology-supported counselors
-
批准号:9109927
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2016
-
负责人:Paula Anne Newman-Casey
-
依托单位:
海外基金